Despite the convincing evidence that supports the involvement of Hsp60 in the development of Alzheimer’s disease [41], there is a lack of studies on its known inhibitors or regulators that could represent potential therapeutic agents in AD. This evidence concerns the gene HSPD1 and Alzheimer disease.